Protocol management of dysuria, urinary frequency, and vaginal discharge.
A proctocol to be administered by nurses for the management of dysuria, frequent urination, and vaginal discharge was validated. In a randomized, controlled trial, 146 women were seen by both nurse and physician and then assigned to either the nurse-proctocol treatment plan or the physician treatment plan. The clinical data collected by the nurse showed no important differences from the physicians' data. The protocol recommended that 89 percent of the patients be sent home without seeing the physician. The physicians agreed with the protocol-recommended disposition in all but two cases. All patients with complications were appropriately referred to the physician. In follow-up, more than 95 percent of both groups reported symptomatic improvement, and repeat urine cultures were negative. We conclude that the protocol can be accurately administered, makes sound recommendations, is safe, and efficiently saves physician time.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D009726:Nurses; D010820:Physicians; D013444:Sulfisoxazole / Q000627:therapeutic use; D013577:Syndrome; D013752:Tetracycline / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000175:diagnosis / Q000188:drug therapy; D014522:Urethral Diseases / Q000175:diagnosis; D014526:Urethritis / Q000175:diagnosis; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000188:drug therapy; D014555:Urination Disorders / Q000175:diagnosis / Q000188:drug therapy*; D014621:Vagina / Q000378:metabolism; D014623:Vaginal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D014627:Vaginitis / Q000175:diagnosis / Q000188:drug therapy
D013444:Sulfisoxazole; D000667:Ampicillin; D013752:Tetracycline